FindTrial
Sign In

Traumatic stress: Prevalence and Intervention in Groups Exposed to Critical Incidents

PTSD: Prevalence and Assessment of an Intervention in Groups Exposed to Critical Incidents

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9z95r5
Enrollment
Unknown
Registered
2018-06-04
Start date
2018-06-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic stress disorder

Interventions

Experimental group: 40 professionals of the emergency services with symptoms of posttraumatic stress disorder receive 3-5 sessions (to be determined) of "Rebirthing-Breathwork". Control group: 40 prof
Other

Sponsors

Programa de Pós-Graduação em Psicologia da Universidade Federal de Santa Catarina
Lead Sponsor
Corpo de Bombeiros Militar de Santa Catarina
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Volunteers belonging to a group exposed to critical incidents; 18 year or above; clinical or subclinical level of posttraumatic stress disorder

Exclusion criteria

Exclusion criteria: Volunteers who have suffered multiple-incident childhood trauma; volunteers who have previously been diagnosed with mental disorders other than posttraumatic stress disorder, acute stress disorder, or depression- or anxiety-related disorders; volunteers who have received medical, psychiatric or psychological treatment for traumatic stress disorders, depression or anxiety in the year preceding the trail; volunteers who are presently receiving medical, psychiatric or psychological treatment for mental disorders

Design outcomes

Primary

MeasureTime frame
Significant reduction in PTSD-symptoms based on the diagnostic criteria B-E for PTSD in DSM-5. Diagnostic test used: Clinician-Administered PTSD Scale for DSM-5. Administered 1-7 days before start of the treatment and 1-7 days after the final treatment session. Self-report measure used: PTSD Checklist for DSM-5. Administered 1-7 days before start of the treatment and 1-7 days after the final treatment session. Reduction of mean pre- and post treatment scores by at least 2SD ;Significant increase in heart-rate variability (HRV) - measured via ECG 1-7 days before start of the treatment and 1-7 days after the final treatment session—

Secondary

MeasureTime frame
Reduction in blood pressure, measured 1-7 days before start of the treatment and 1-7 days after the final treatment session—

Countries

Brazil

Contacts

Public ContactPaulus;Roberto de Wit;Moraes Cruz

Programa de Pós-Graduação em Psicologia da Universidade Federal de Santa Catarina;Programa de Pós-Graduação em Psicologia da Universidade Federal de Santa Catarina

pdwpsi@gmail.com;robertocruzdr@gmail.com+55-048-998491593;+55-048-37213512

Outcome results

None listed

Source: REBEC (via WHO ICTRP)